相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+ T and NK Cells
Xin Gao et al.
JOURNAL OF IMMUNOLOGY (2015)
Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue
Kazuya Ishikawa et al.
AURIS NASUS LARYNX (2014)
Serum soluble ST2 is associated with ER-positive breast cancer
Da-peng Lu et al.
BMC CANCER (2014)
IL-33 attenuates the development of experimental autoimmune uveitis
Mark Barbour et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Emerging role of interleukin-33 in autoimmune diseases
Cheng Pei et al.
IMMUNOLOGY (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Enhancement of the p38 MAPK and PKA signaling pathways is associated with the pro-melanogenic activity of Interleukin 33 in primary melanocytes
Jia Zhou et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-κB and ERK1/2 signaling
Wen-Ting Hu et al.
MOLECULAR HUMAN REPRODUCTION (2014)
Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells
Kuan-Min Fang et al.
NEURO-ONCOLOGY (2014)
Significance of interleukin-33 and its relatec cytokines in patients with breast cancers
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Serum IL-33 as a Diagnostic and Prognostic Marker in Nonsmall Cell Lung Cancer
Liang-An Hu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
Kun Gao et al.
CANCER LETTERS (2013)
Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue
M. Zeyda et al.
INTERNATIONAL JOURNAL OF OBESITY (2013)
The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma
Su-Feng Chen et al.
JOURNAL OF PATHOLOGY (2013)
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancer
Vincent Lavoue et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
Dominik Bergis et al.
TRANSLATIONAL ONCOLOGY (2013)
Interleukin-33 acts as a pro-inflammatory cytokine and modulates its receptor gene expression in highly metastatic human pancreatic carcinoma cells
Annett Schmieder et al.
CYTOKINE (2012)
IL-33 attenuates EAE by suppressing IL-17 and IFN-γ production and inducing alternatively activated macrophages
Hui-Rong Jiang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
IL-33/ST2 axis in inflammation and immunopathology
Marija Milovanovic et al.
IMMUNOLOGIC RESEARCH (2012)
Serum Interleukin-33 Levels in Patients with Gastric Cancer
Pinghu Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
IL-33-activated dendritic cells are critical for allergic airway inflammation
Anne-Gaelle Besnard et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
Yeon-Sook Choi et al.
BLOOD (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation
Mariola Kurowska-Stolarska et al.
JOURNAL OF IMMUNOLOGY (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon
RT Marquez et al.
CLINICAL CANCER RESEARCH (2005)
Screening for familial ovarian cancer: Failure of current protocols to detect ovarian cancer at an early stage according to the International Federation of Gynecology and Obstetrics System
D Stirling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Histologic types of epithelial ovarian cancer: have they different risk factors?
AW Kurian et al.
GYNECOLOGIC ONCOLOGY (2005)
Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules
ES Baekkevold et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Expression and function of the ST2 gene in a murine model of allergic airway inflammation
K Oshikawa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2002)
Relapsed ovarian cancer: Challenges and management strategies for a chronic disease
DK Armstrong
ONCOLOGIST (2002)
分享论文
